This article was originally published in The Rose Sheet
Executive SummaryPaul De Bruecker is named senior VP and general manager of Schwarzkopf & Henkel in the U.S. and Canada, overseeing hair care brands got2b, L.A. Looks, Dep and Citre Shine, firm announces Aug. 1. Under his leadership, Henkel expects to accelerate marketing and product development efforts in North America, a targeted growth region, firm adds. Exec, who replaces Thomas Parr, has been with Henkel for more than 15 years, most recently serving as general manager of Schwarzkopf & Henkel in Austria. Henkel's Cosmetics/Toiletries division revenue advanced 4.1% to $843.5 mil. (€1=$1.23) in the second quarter, after adjusting for foreign currency effects, firm says Aug. 3. North American sales increased 18.7% after adjusting for foreign exchange to $828.7 mil., due primarily to acquisitions. Net revenues were up 10% to $3.71 bil. after adjusting for exchange. Earnings grew .5% to $241.7 mil. after minority interests...
You may also be interested in...
Farah Ahmed, president and CEO of the Fragrance Creators Association, discusses the trade group’s expansion in recent years beyond immediate regulatory and legislative concerns to a platform for robust member collaboration in the name of positively impacting the world.
The amyloid-targeting drug is years behind Biogen/Eisai’s aducanumab, but its subcutaneous administration and the GRADUATE studies’ design could give Roche’s gantenerumab an advantage.
Correvio's atrial fibrillation drug Brinavess will return to a US FDA advisory committee more than a decade after the agency first declined to approve the drug; FDA still has a series of cardiovascular safety concerns related to the drug and is not convinced by data from the European experience.